DOT
1L methylates histone H3K79 and is aberrantly regulated in
MLL
‐rearranged leukemia. Inhibitors have been developed to target
DOT
1L activity in leukemia, but cellular mechanisms that regulate
DOT
1L are still poorly understood. We have identified the histone deacetylase Rpd3 as a negative regulator of budding yeast Dot1. At its target genes, the transcriptional repressor Rpd3 restricts H3K79 methylation, explaining the absence of H3K79me3 at a subset of genes in the yeast genome. Similar to the crosstalk in yeast, inactivation of the murine Rpd3 homolog
HDAC
1 in thymocytes led to an increase in H3K79 methylation. Thymic lymphomas that arise upon genetic deletion of
Hdac1
retained the increased H3K79 methylation and were sensitive to reduced
DOT
1L dosage. Furthermore, cell lines derived from
Hdac1
Δ/Δ
thymic lymphomas were sensitive to a
DOT
1L inhibitor, which induced apoptosis. In summary, we identified an evolutionarily conserved crosstalk between
HDAC
1 and
DOT
1L with impact in murine thymic lymphoma development.